Skip to main content

Table 2 Endoscopic data

From: The role of endoscopy and findings in COVID-19 patients, an early North American Cohort

Procedure

 

Endoscopy, n (%)

18 (75)

Colonoscopy, n (%)

7 (29.2)

ERCP, n (%)

2 (8.3)

Type of sedation, n (%)

Conscious

6 (25)

MAC

8 (33.3)

General

10 (41.7)

Reason for endoscopy

 

 Need for enteral access, n (%)

6 (25)

 Overt Bleeding, n (%)

13 (54.2)

 Anemia without overt bleeding, n (%)

1 (4.2) (OGT placed during EGD as well)

 Biliary decompression, n (%)

2 (8.3)

 Diarrhea, n (%)

1 (4.2)

 Obstruction, n (%)

1 (4.2)

Need for intervention, n (%)

GI Bleed

2 (8.3)

Enteral feeding access

6 (25)

Biliary decompression

2 (8.3)

Endoscopic findings

 

 Endoscopy n = 18, n (%)

Enteral tube placement

6 (33.3)

Inflammation/ulcers

10 (55.6)

AVM

1 (5.6)

Varices

1 (5.6)

Normal

1 (5.6) (one for OGT placement)

 Colonoscopy n = 7, n (%)

Diverticulosis

2 (8.6)

Hemorrhoids

3 (42.9)

Rectal ulcer

1 (14.3)

Blood without source

1 (14.3)

Normal

1 (14.3)

 ERCP n = 2, n (%)

Choledocholithiasis

1 (50)

Biliary Sludge

1 (50)

 Related to COVID, n (%)

Yes

2 (8.3)

No

22 (91.7)